Cisplatin Induces Hearing Loss in Most Pediatric Patients With High-Risk Neuroblastoma

3 minutes ago
1 min read

Following induction treatment for high-risk neuroblastoma, more than half of children experience cisplatin-induced hearing loss (CIHL), according to research published in JCO Clinical Advances.

Comments

Cisplatin Induces Hearing Loss in Most Pediatric Patients With High-Risk Neuroblastoma

Breakthrough In Highly Lethal Childhood Cancer Could Change The Natural History of The Disease

Pediatric Oncology Keeps Getting Treated as an Afterthought. The Biology Disagrees.

Lifestyle can protect childhood cancer survivors

Long-term Pediatric PFT Survivors Face Functional Challenges

Scientists target root of relapse in aggressive childhood brain tumors

New study traces rare form of childhood leukaemia back to before birth

Researchers identify new indicator for response to therapy in pediatric cancers

Pediatric Non-Hispanic Black AML and ALL Patients Have Increased Risks for Acute Kidney Injury

Fertility and other considerations when treating cancer in adolescents and young adults

Recent Posts

Cisplatin Induces Hearing Loss in Most Pediatric Patients With High-Risk Neuroblastoma

Comments

Cisplatin Induces Hearing Loss in Most Pediatric Patients With High-Risk Neuroblastoma

Breakthrough In Highly Lethal Childhood Cancer Could Change The Natural History of The Disease

Pediatric Oncology Keeps Getting Treated as an Afterthought. The Biology Disagrees.

Lifestyle can protect childhood cancer survivors

Long-term Pediatric PFT Survivors Face Functional Challenges

Scientists target root of relapse in aggressive childhood brain tumors

New study traces rare form of childhood leukaemia back to before birth

Researchers identify new indicator for response to therapy in pediatric cancers

Pediatric Non-Hispanic Black AML and ALL Patients Have Increased Risks for Acute Kidney Injury

Fertility and other considerations when treating cancer in adolescents and young adults

Archive

Search By Tags